- Specification
- Background
- Scientific Data
- Q & A
- Customer Review
SK-GT-4 is a rigorously authenticated human esophageal adenocarcinoma (EAC) cell line established in 1989 from a well-differentiated adenocarcinoma arising from Barrett's mucosa in an 83-year-old male patient. As one of only ten EAC lines whose identity has been verified against original patient material through STR profiling, p53 mutation analysis, and xenograft histology, SK-GT-4 offers exceptional model fidelity in a field historically plagued by misidentified lines.
Molecularly, SK-GT-4 is comprehensively annotated through publicly available whole-genome sequencing data. It harbors a pathogenic KRAS mutation and an MSH2 missense variant, alongside recurrent copy-number alterations characteristic of EAC—including gains in ERBB2, MYC, MET, and SEMA5A, and losses in SMAD4 and CDKN2A. Its aneuploid karyotype (mode 59 chromosomes) and high mutational burden faithfully recapitulate the genomic complexity of primary EAC, closely mirroring TCGA profiles.
Functionally, SK-GT-4 demonstrates robust proliferative capacity and documented chemosensitivity to paclitaxel via G2/M arrest and caspase-3–mediated apoptosis. The line has been extensively utilized in high-throughput drug screening, circulating tumor cell detection validation, and mechanistic studies of EAC progression and metastasis. With authenticated origin, Barrett's-associated histogenesis, comprehensive genomic annotation, and proven experimental versatility, SK-GT-4 stands as a cornerstone model for advancing EAC biology and therapeutic discovery.
New N-Heterocyclic Carbene Gold and Platinum Complexes with 1,3-Dialkyl-4-anisyl-5-(4-chlorophenyl)imidazol-2-ylidene Ligands for the Treatment of Esophageal Adenocarcinoma
The dose- and time-dependent activity of the cationic NHC-gold(I) complexes 8 (G2) and 11 (G4) against esophageal adenocarcinoma (EAC) cells was investigated and compared with the activity of auranofin.
Their potential to induce apoptosis in SK-GT-4 and OE33 EAC cells was assessed using AnnexinV/PI assay and flow cytometry. Notably, cells treated with 8 and 11 (IC50 concentrations) for 72 h showed a considerable induction of both early and late apoptotic cells but only marginal numbers of necrotic cells, compared with untreated control populations (Fig. 1).
As another indicator of apoptosis induction, the activation of caspases 3 and 7 by complexes 8 and 11 was studied (Fig. 2). Both gold complexes 8 (1.7 and 1.9 µM, respectively) and 11 (0.9 and 0.7 µM, respectively) exhibited a 3–4-fold increase in caspase 3 and 7 activity in SK-GT-4 and FLO-1 EAC cells. The cells were then treated with auranofin, as previously reported, as it induces caspase 3/7 activity in a dose-dependent manner. However, when the cells were treated with 8 (G2) or auranofin, an equivalent dose of the most potent compound, 11 (G4), did not result in significant caspase 3/7 activity in SK-GT-4 and FLO-1 cells, suggesting the superiority of complex 11 (G4) in inducing apoptosis.
Ask a Question
Write your own review
- Adipose Tissue-Derived Stem Cells
- Human Neurons
- Mouse Probe
- Whole Chromosome Painting Probes
- Hepatic Cells
- Renal Cells
- In Vitro ADME Kits
- Tissue Microarray
- Tissue Blocks
- Tissue Sections
- FFPE Cell Pellet
- Probe
- Centromere Probes
- Telomere Probes
- Satellite Enumeration Probes
- Subtelomere Specific Probes
- Bacterial Probes
- ISH/FISH Probes
- Exosome Isolation Kit
- Human Adult Stem Cells
- Mouse Stem Cells
- iPSCs
- Mouse Embryonic Stem Cells
- iPSC Differentiation Kits
- Mesenchymal Stem Cells
- Immortalized Human Cells
- Immortalized Murine Cells
- Cell Immortalization Kit
- Adipose Cells
- Cardiac Cells
- Dermal Cells
- Epidermal Cells
- Peripheral Blood Mononuclear Cells
- Umbilical Cord Cells
- Monkey Primary Cells
- Mouse Primary Cells
- Breast Tumor Cells
- Colorectal Tumor Cells
- Esophageal Tumor Cells
- Lung Tumor Cells
- Leukemia/Lymphoma/Myeloma Cells
- Ovarian Tumor Cells
- Pancreatic Tumor Cells
- Mouse Tumor Cells